Whatfinger NewsFingerFlickEntertainmentFinger Deals
Ratings

The numbers, both columns, named meter.

Whatfinger News · Ratings desk

PHARMA ADS

Where the drug companies put the money. Network share, the drugs on the screen, and the evening-news block that takes the buy.

iSpot estimates via published trade reports · two fractions, labeled · a network’s share of pharma dollars is not pharma’s share of that network

September 2026 monthly via iSpot · streaming now in the monthly cut · 2025 year and network share stay below, different meters

September 1
$56.9M
Bimzelx · 54% streaming
September 2
$52.5M
Foundayo · Lilly obesity pill
Pharma, all TV
14%
Jan–Aug 2025 · $3.73 billion
Fox News share
1.9%
Of those 2025 drug dollars

Advertisement

SEPTEMBER 2026, TOP DRUGS

iSpot now folds streaming into the monthly cut. These dollars are not comparable to the 2025 linear-only year table below.

DrugCompanyConditionSpendStreaming
BimzelxUCBImmunology$56.9 million53.85%
FoundayoEli LillyObesity pill$52.5 million63.05%
SkyriziAbbVieImmunology$44.7 million33.84%
RinvoqAbbVieImmunology$40.7 million31.91%
TremfyaJohnson & JohnsonImmunology$40.3 million26.25%
WegovyNovo NordiskObesity$37.7 million53.82%
CaplytaJohnson & JohnsonDepression, bipolar$34.6 million39.42%
IcotydeJohnson & JohnsonPsoriasis$33.1 million38.39%
ZepboundEli LillyObesity$24.3 million18.29%
VraylarAbbVieNeurology$22.3 million42.28%

iSpot via Fierce Pharma, September 2026, published Oct 12. First month the monthly list includes streaming.

WHO TAKES THE DRUG DOLLARS

January through August 2025. This is each network’s share of pharmaceutical TV spending, not the share of that network’s own ads that are pills.

NetworkShare of pharma TV dollars
ABC16.91%
CBS15.46%
NBC14.73%
FOX5.15%
ESPN2.44%
Fox News1.92%
TBS1.91%
HGTV1.85%
Food Network1.79%
TNT1.64%
All other45.31%

Pharma spent $3.73 billion on TV ads in those eight months, 14 percent of all TV ad spending. ABC, CBS, and NBC took close to half the drug dollars. Source: industry tally reported by StudyFinds, Sept 2025.

JUNE 2026, BY IMPRESSIONS

A different cut. Share of pharma impressions that month, not dollars, and not the 2025 table above.

NetworkPharma impression share
CBS11.51%
ABC9.95%
Fox News9.65%
NBC7.27%
MS NOW4.66%

iSpot via MM+M, June 2026. Top linear program that month: ABC World News Tonight with David Muir, 2.37 percent of pharma impressions. CBS was the biggest network destination.

2025, TOP DRUGS ON TV

Estimated national TV spend. Immunology and the weight-loss shots are the buy. Top 10 brands combined: $2.67 billion.

DrugCompanyConditionSpend
SkyriziAbbViePsoriasis, Crohn’s, colitis$439.6 million
TremfyaJohnson & JohnsonPsoriasis, Crohn’s, colitis$431 million
RinvoqAbbVieEczema, colitis, arthritis$376.4 million
WegovyNovo NordiskObesity$298.1 million
DupixentSanofi / RegeneronEczema, asthma$241.3 million
RexultiLundbeck / OtsukaDepression, Alzheimer’s$241.1 million
CaplytaJohnson & JohnsonDepression, bipolar$185.7 million
JardianceLilly / BoehringerDiabetes, kidney disease$171.5 million
ZepboundEli LillyObesity$160.1 million
VraylarAbbVieBipolar, depression$128.9 million

iSpot national TV estimates via Fierce Pharma, full-year 2025, published Jan 16, 2026. AbbVie owns three of the ten.

Advertisement

Evening news is the shelf

In 2024, prescription brands put 22.3 percent of national linear spend into news and information, and 17.6 percent into sports. ABC, CBS, Fox, ESPN, and NBC combined took 52.8 percent of those dollars.

The broadcast evening newscasts are where a large share of that news buy lands. Fox News took 1.92 percent of the 2025 drug dollars in the eight-month tally. The impression cut in June 2026 is higher. Both numbers stay on the page. They are not the same meter.

THE BUY IS MOVING

Prescription ads on TV and streaming, 2026.

QuarterSpendStreaming share
Q1 2026$2.52 billion32%
Q2 2026$2.04 billion—
Q3 2026$1.99 billion42%

iSpot via eMarketer, Oct 9, 2026. Streaming’s share of prescription TV dollars rose from 32 percent in the first quarter to 42 percent in the third. Linear is still the evening-news story. The same companies are moving part of the buy.

2024 baseline: prescription brands spent $5.15 billion on national linear TV, 11.6 percent of ad dollars on national broadcast and cable. Guideline / MediaRadar transparency report.

Advertisement